Well it was reasonable for OIL to provide us with the good news of technology use in cancer research in NY before the interim result. However I'm sure anyone who bought on the strength of these announcements is starting to wonder when the directors became aware of the deferral of deliveries to Zeiss. In the short term this appears to have had the largest impact on the share price.
- Forums
- ASX - By Stock
- Ann: OptiScan technology used in research at major cancer centre
Well it was reasonable for OIL to provide us with the good news...
Featured News
Add OIL (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.0¢ |
Change
0.020(14.3%) |
Mkt cap ! $129.4M |
Open | High | Low | Value | Volume |
16.0¢ | 16.5¢ | 15.5¢ | $6.478K | 39.93K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 17733 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.040 |
1 | 23529 | 0.034 |
1 | 63140 | 0.033 |
1 | 25000 | 0.024 |
1 | 60000 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 20000 | 1 |
0.045 | 93965 | 2 |
0.048 | 100000 | 1 |
0.049 | 225000 | 1 |
0.050 | 87172 | 3 |
Last trade - 15.18pm 25/11/2024 (20 minute delay) ? |
Featured News
OIL (ASX) Chart |